oligomycin

Oligomycin binds to the F0 subunit of ATP synthase (Complex V), blocking the flow of protons back into the mitochondrial matrix through the synthase. This prevents ATP production despite an intact proton gradient. Because the proton gradient cannot dissipate through ATP synthase, oxygen consumption also decreases (since electron transport is indirectly coupled to ATP synthase activity via the proton gradient) - this is a key distinguishing feature from uncouplers like 2,4-dinitrophenol (DNP), which increase oxygen consumption while decreasing ATP synthesis by dissipating the proton gradient directly across the membrane. This concept is frequently tested in USMLE Step 1 with graphs showing oxygen consumption vs. ATP synthesis rates under electron transport chain inhibitors, ATP synthase inhibitors, and uncouplers. Clinically, oligomycin is primarily a laboratory tool for studying mitochondrial bioenergetics rather than a therapeutic agent, though understanding its mechanism helps clarify concepts relevant to mitochondrial toxicity from drugs (e.g., certain antiretrovirals) and diseases (e.g., mitochondrial myopathies). Students should be able to differentiate the actions of electron transport chain inhibitors (e.g., cyanide, carbon monoxide, antimycin A, rotenone) from ATP synthase inhibitors (oligomycin) and uncoupling agents (DNP, aspirin overdose, thermogenin in brown fat).